StockData

Nika Pharmaceuticals, Inc (NIKA) stock

NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 0/30
$0.41+0.00 (0.00%)

Close on Oct 16, 2026Market cap $431.19MP/E –Yield –

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-376.1%vs -40.6%
Return on invested capital-536.8%vs -31.9%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $337.69K.

Total debt$340.62K
Cash and short-term investments$2.93K
EBITDA, trailing twelve months-$78.14K

Leverage and liquidity

Current ratio0.03vs 3.28
Quick ratio0.01vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

3 of 9 tests passed

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 16, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

NIKAS&P 500
PeriodNIKAS&P 500DifferenceNIKA per yearS&P 500 per year
1 month0.0%+1.5%−1.5 pts
3 months-46.7%+1.9%−48.6 pts
Year to date+7.9%+12.8%−4.9 pts
1 year-14.4%+16.8%−31.2 pts

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M NIKA shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026420.0%8361.0
Oct 15, 202642-40.0%410.5
Sep 30, 2026700.0%154.7
Sep 15, 2026700.0%01000.0
Aug 31, 2026700.0%5341.0
Aug 14, 202670+6900.0%5501.0
Jul 31, 202610.0%171.0
Jul 15, 202610.0%101.0
Jun 30, 202610.0%7361.0
Jun 15, 202610.0%521.0
May 29, 202610.0%461.0
May 15, 202610.0%811.0

Every measure, in full

23 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (QoQ)
0.30%
0.58%
Float
596M
49M
Shares Held by Insiders
43.3%
11.1%

Returns on capitalIndustry

Return on Assets (ROA)
-376.1%
-40.6%
Return on Invested Capital (ROIC)
-536.8%
-31.9%

Financial positionIndustry

Current Ratio
0.03
3.28
Quick Ratio
0.01
2.37

Income statement (TTM)Industry

Operating Income
-$78.14K
-$21.49M
Pretax Income
-$78.14K
-$14.83M
Net Income
-$78.14K
-$22.47M
EBITDA
-$78.14K
-$17.14M
EPS (Diluted)
$0.00
-$0.83

Balance sheetIndustry

Total Debt
$340.62K
$114.91M
Net Cash (Debt)
-$337.69K
$15.31M
Net Cash Per Share
-$0.00
$0.72
Equity (Book Value)
-$330.68K
$49.40M
Book Value Per Share
-$0.00
$1.45
Tangible Book Value
-$330.68K
$23.58M
Working Capital
-$330.68K
$74.34M

Cash flow (TTM)Industry

Operating Cash Flow
-$69.14K
-$12.15M

Scores and fair valueIndustry

Piotroski F-Score
3
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?